Published in Circulation on January 29, 2007
Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). JACC Heart Fail (2014) 1.41
Prognostic value of estimating functional capacity with the use of the duke activity status index in stable patients with chronic heart failure. J Card Fail (2014) 0.98
Influence of a symptom management telehealth intervention on older adults' early recovery outcomes after coronary artery bypass surgery. Heart Lung (2009) 0.96
Pre-operative health status and outcomes after continuous-flow left ventricular assist device implantation. J Heart Lung Transplant (2013) 0.84
Physical distress is associated with cardiovascular events in a high risk population of elderly men. BMC Cardiovasc Disord (2009) 0.81
Prognostic value of estimated functional capacity incremental to cardiac biomarkers in stable cardiac patients. J Am Heart Assoc (2014) 0.80
Prognostic value of preoperative quality of life on mortality after isolated elective myocardial revascularization. Interact Cardiovasc Thorac Surg (2012) 0.79
Symptom burden clusters and their impact on psychosocial functioning following coronary artery bypass surgery. J Cardiovasc Nurs (2010) 0.75
Predicting long-term prognosis in stable peripheral artery disease with baseline functional capacity estimated by the Duke Activity Status Index. Am Heart J (2016) 0.75
The Effect of Health Promoting Programs on Patient's Life Style After Coronary Artery Bypass Graft-Hospitalized in Shiraz Hospitals. Glob J Health Sci (2015) 0.75
Health-Related Quality of Life, Functional Status, and Cardiac Event-Free Survival in Patients With Heart Failure. J Cardiovasc Nurs (2016) 0.75
Patient and spouse perceived quality of life five years after coronary artery bypass graft surgery. Open Nurs J (2008) 0.75
Association of global and disease-specific health status with outcomes following continuous-flow left ventricular assist device implantation. BMC Cardiovasc Disord (2017) 0.75
The use of health related quality of life measurement in cardiovascular and pulmonary physical therapy practice: an exploratory study. Cardiopulm Phys Ther J (2010) 0.75
HMDB: the Human Metabolome Database. Nucleic Acids Res (2007) 13.38
HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res (2008) 11.23
Duration of red-cell storage and complications after cardiac surgery. N Engl J Med (2008) 10.04
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med (2013) 6.33
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Prospective trial of a pediatric ventricular assist device. N Engl J Med (2012) 4.72
Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med (2006) 4.59
7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol (2010) 4.52
FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell (2009) 4.48
A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery. J Am Coll Cardiol (2013) 4.46
Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med (2003) 3.87
Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. J Am Coll Cardiol (2004) 3.50
Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation. Arch Intern Med (2012) 3.47
Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg (2004) 3.38
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol (2011) 3.37
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Use of annulus washer after debridement: a new mitral valve replacement technique for patients with severe mitral annular calcification. J Thorac Cardiovasc Surg (2013) 3.31
The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol (2006) 3.25
Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell (2012) 2.96
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol (2012) 2.78
Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease. J Am Coll Cardiol (2003) 2.76
Temporal onset, risk factors, and outcomes associated with stroke after coronary artery bypass grafting. JAMA (2011) 2.73
Robotic repair of posterior mitral valve prolapse versus conventional approaches: potential realized. J Thorac Cardiovasc Surg (2010) 2.69
NHLBI strategic visioning: setting an agenda together for the NHLBI of 2025. Am J Respir Crit Care Med (2015) 2.60
Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Autophagy (2011) 2.47
Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg (2006) 2.42
Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg (2004) 2.37
A novel approach to cancer staging: application to esophageal cancer. Biostatistics (2009) 2.31
Surgical treatment of postinfarction left ventricular pseudoaneurysm. Ann Thorac Surg (2007) 2.26
Impact of prosthesis-patient size on functional recovery after aortic valve replacement. Circulation (2005) 2.26
Are all readmissions bad readmissions? N Engl J Med (2010) 2.22
Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol (2007) 2.20
Refining esophageal cancer staging. J Thorac Cardiovasc Surg (2003) 2.18
Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? J Thorac Cardiovasc Surg (2010) 2.16
A randomized trial of massage therapy after heart surgery. Heart Lung (2009) 2.13
Detecting bacteria and determining their susceptibility to antibiotics by stochastic confinement in nanoliter droplets using plug-based microfluidics. Lab Chip (2008) 2.11
Editorial: An 'actual' problem: Another issue of apples and oranges. J Heart Valve Dis (2005) 2.11
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11
Influence of patient characteristics and arterial grafts on freedom from coronary reoperation. J Thorac Cardiovasc Surg (2005) 2.09
Does off-pump coronary surgery reduce morbidity and mortality? J Thorac Cardiovasc Surg (2002) 2.08
Percentile ranking and citation impact of a large cohort of National Heart, Lung, and Blood Institute-funded cardiovascular R01 grants. Circ Res (2014) 2.08
Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation (2013) 2.07
Association of pulmonary conduit type and size with durability in infants and young children. Ann Thorac Surg (2013) 2.06
Guidelines for reporting mortality and morbidity after cardiac valve interventions. Ann Thorac Surg (2008) 2.04
The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thorac Surg (2004) 2.03
Optimum lymphadenectomy for esophageal cancer. Ann Surg (2010) 2.01
The role of aspirin in the prevention of thrombotic complications of thalidomide and anthracycline-based chemotherapy for multiple myeloma. Mayo Clin Proc (2005) 2.00
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg (2012) 1.99
Adverse events during reoperative cardiac surgery: frequency, characterization, and rescue. J Thorac Cardiovasc Surg (2008) 1.99
Perioperative management and treatment for complications during and after peroral endoscopic myotomy (POEM) for esophageal achalasia (EA) (data from 119 cases). Surg Endosc (2012) 1.98
The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 1.96
Guidelines for reporting data and outcomes for the surgical treatment of atrial fibrillation. Ann Thorac Surg (2007) 1.91
Identification of bacteria using tandem mass spectrometry combined with a proteome database and statistical scoring. Anal Chem (2004) 1.89
The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol (2008) 1.88
Surgical treatment of pseudoaneurysm of the thoracic aorta. J Thorac Cardiovasc Surg (2006) 1.88
SlipChip. Lab Chip (2009) 1.84
Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery. Ann Thorac Surg (2006) 1.80
Truncus arteriosus associated with interrupted aortic arch in 50 neonates: a Congenital Heart Surgeons Society study. Ann Thorac Surg (2006) 1.78
Identification and characterization of microRNAs in raw milk during different periods of lactation, commercial fluid, and powdered milk products. Cell Res (2010) 1.77
Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg (2008) 1.76
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg (2012) 1.74
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J (2012) 1.72
Toward predictable repair of regurgitant aortic valves: a systematic morphology-directed approach to bicommissural repair. J Am Coll Cardiol (2008) 1.71
What is the preferred therapy for patients with aortic coarctation--the standard gamble and decision analysis versus real results? Cardiol Young (2007) 1.71
Patient and surgical factors influencing air leak after lung volume reduction surgery: lessons learned from the National Emphysema Treatment Trial. Ann Thorac Surg (2006) 1.71
Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation. Ann Thorac Surg (2006) 1.71
A critical evaluation of a percutaneous diagnostic and treatment strategy for chylothorax after thoracic surgery. Eur J Cardiothorac Surg (2008) 1.69
Repair versus replacement for degenerative mitral valve disease with coexisting ischemic heart disease. J Thorac Cardiovasc Surg (2003) 1.69
Core/Shell semiconductor nanocrystals. Small (2009) 1.68
A novel running annuloplasty suture technique for robotically assisted mitral valve repair. J Thorac Cardiovasc Surg (2010) 1.68
Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol (2012) 1.66
Atrial fibrillation: current surgical options and their assessment. Ann Thorac Surg (2002) 1.66
Outcomes after the Norwood operation in neonates with critical aortic stenosis or aortic valve atresia. J Thorac Cardiovasc Surg (2003) 1.65
Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Ann Thorac Surg (2008) 1.65
Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol (2002) 1.64
Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg (2008) 1.64
Regional wall motion abnormalities and scarring in severe functional ischemic mitral regurgitation: A pilot cardiovascular magnetic resonance imaging study. J Thorac Cardiovasc Surg (2009) 1.63
Importance of treadmill exercise time as an initial prognostic screening tool in patients with systolic left ventricular dysfunction. Circulation (2009) 1.63
Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation (2006) 1.61
Perioperative management of acquired von Willebrand disease in cardiac surgery: type 2B or not 2B? J Cardiothorac Vasc Anesth (2010) 1.61
Emergency coronary artery bypass surgery in the contemporary percutaneous coronary intervention era. Circulation (2002) 1.60
Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration of allograft and pericardial prostheses. J Thorac Cardiovasc Surg (2006) 1.60
Surgery for permanent atrial fibrillation: impact of patient factors and lesion set. Ann Thorac Surg (2006) 1.59
Does the arterial cannulation site for circulatory arrest influence stroke risk? Ann Thorac Surg (2004) 1.59
Effect of off-pump coronary artery bypass graft surgery on postoperative acute kidney injury and mortality. Crit Care Med (2006) 1.59
Ventilatory dependency after cardiovascular surgery. J Thorac Cardiovasc Surg (2007) 1.58
Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists' treatment: a meta-analysis of randomized controlled trials. Endocrine (2014) 1.58
Robotic posterior mitral leaflet repair: neochordal versus resectional techniques. Ann Thorac Surg (2012) 1.57
Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma. J Thorac Cardiovasc Surg (2003) 1.57